ES2057565T3 - Tratamiento de trastornos de la motilidad con un analogo de gnrh. - Google Patents

Tratamiento de trastornos de la motilidad con un analogo de gnrh.

Info

Publication number
ES2057565T3
ES2057565T3 ES90907817T ES90907817T ES2057565T3 ES 2057565 T3 ES2057565 T3 ES 2057565T3 ES 90907817 T ES90907817 T ES 90907817T ES 90907817 T ES90907817 T ES 90907817T ES 2057565 T3 ES2057565 T3 ES 2057565T3
Authority
ES
Spain
Prior art keywords
treatment
gnrh
motility
disorders
analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90907817T
Other languages
English (en)
Inventor
John R Mathias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2057565T3 publication Critical patent/ES2057565T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN TRATAMIENTO PARA ALIVIAR LOS SINTOMAS DE DEBILITACION DE TRASTORNOS DE MOTILIDAD, INCLUIDOS LOS TRASTORNOS FUNCIONALES DE LOS INTESTINOS. EL TRATAMIENTO DE PACIENTES CON ANALOGICOS DE GNRH REDUCE SIGNIFICATIVAMENTE O ELIMINA LOS SINTOMAS DE TRASTORNOS DE MOTILIDAD, INCLUIDOS LOS TRASTORNOS FUNCIONALES DE LOS INTESTINOS.
ES90907817T 1989-05-09 1990-05-03 Tratamiento de trastornos de la motilidad con un analogo de gnrh. Expired - Lifetime ES2057565T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/349,717 US5068221A (en) 1989-05-09 1989-05-09 Treatment of motility disorders with a gnrh analog

Publications (1)

Publication Number Publication Date
ES2057565T3 true ES2057565T3 (es) 1994-10-16

Family

ID=23373648

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90907817T Expired - Lifetime ES2057565T3 (es) 1989-05-09 1990-05-03 Tratamiento de trastornos de la motilidad con un analogo de gnrh.

Country Status (13)

Country Link
US (1) US5068221A (es)
EP (1) EP0471761B1 (es)
JP (1) JPH04505016A (es)
KR (1) KR920700676A (es)
AT (1) ATE110277T1 (es)
AU (2) AU628763B2 (es)
CA (1) CA2053880C (es)
DE (1) DE69011857T2 (es)
DK (1) DK0471761T3 (es)
ES (1) ES2057565T3 (es)
IL (1) IL94330A (es)
NZ (1) NZ248242A (es)
WO (1) WO1990013308A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5434136A (en) * 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
US5470847A (en) * 1993-12-10 1995-11-28 Board Of Regents, The University Of Texas System Ovulation control by regulating nitric oxide levels with arginine derivatives
CN1343219A (zh) * 1999-01-28 2002-04-03 中外制药株式会社 取代的苯乙基胺衍生物
AU2004238263A1 (en) * 2003-05-06 2004-11-25 Syntonix Pharmaceuticals, Inc. Inhibition of drug binding to serum albumin
EP3876748B1 (en) * 2018-11-09 2025-09-24 IMS Trading, LLC Edible pet chews and methods of forming the same

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO139560C (no) * 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
CA1009230A (en) * 1972-09-26 1977-04-26 Daiichi Seiyaku Co. Peptides effecting to the release of sex hormones and a method for preparing the same
JPS563846B2 (es) * 1972-10-12 1981-01-27
CS180644B2 (en) * 1973-09-29 1978-01-31 Takeda Chemical Industries Ltd Process for preparing nonapeptides
US3914412A (en) * 1973-10-11 1975-10-21 Abbott Lab {8 Des{13 Gly{9 {0 10 -Gn{13 RH nonapeptide amide analogs in position 6 having ovulation-inducing activity
US4005063A (en) * 1973-10-11 1977-01-25 Abbott Laboratories [Des-gly]10 -GnRH nonapeptide anide analogs in position 6 having ovulation-inducing activity
US4072668A (en) * 1973-11-06 1978-02-07 The Salk Institute For Biological Studies LH-RH Analogs
US4552764A (en) * 1974-11-14 1985-11-12 Research Corporation Peptides for control of intestinal motility
US4010261A (en) * 1974-11-25 1977-03-01 Abbott Laboratories Method to prevent reproduction with [Des-Gly]10 -GN-RH nonadeptide amide analogs in position
US4002738A (en) * 1975-05-30 1977-01-11 Abbott Laboratories Treatment of specified neoplasias
US4005194A (en) * 1975-06-23 1977-01-25 Abbott Laboratories Treatment of prostatic hyperplasia
US4018914A (en) * 1975-11-13 1977-04-19 Abbott Laboratories Parturition inducement
JPS54148722A (en) * 1978-05-12 1979-11-21 Takeda Chem Ind Ltd Nonapeptide and its preparation
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
US4409208A (en) * 1980-04-15 1983-10-11 The Salk Institute For Biological Studies GnRH antagonists
US4410514A (en) * 1982-12-06 1983-10-18 The Salk Institute For Biological Studies GnRH Agonists
US4619914A (en) * 1983-03-10 1986-10-28 The Salk Institute For Biological Studies GNRH antagonists IIIB
US4569927A (en) * 1984-02-23 1986-02-11 The Salk Institute For Biological Studies GnRH Antagonists IV
US4652550A (en) * 1984-05-21 1987-03-24 The Salk Institute For Biological Studies GnRH antagonists VII
US4565804A (en) * 1984-09-07 1986-01-21 The Salk Institute For Biological Studies GnRH Antagonists VI
US4752577A (en) * 1984-09-13 1988-06-21 Eli Lilly And Company Method for using a novel transcriptional- and translational-activating sequence in streptomyces
US4690916A (en) * 1984-11-13 1987-09-01 Syntex (U.S.A.) Inc. Nona and decapeptide analogs of LHRH useful as LHRH antagonists
US4740500A (en) * 1985-01-31 1988-04-26 The Salk Institute For Biological Studies GnRH antagonists VIII
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4661472A (en) * 1985-05-09 1987-04-28 The Salk Institute For Biological Studies GnRH antagonists IX
US4920102A (en) * 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders

Also Published As

Publication number Publication date
IL94330A (en) 1995-03-30
DK0471761T3 (da) 1994-09-19
EP0471761A1 (en) 1992-02-26
EP0471761A4 (en) 1992-06-24
AU628763B2 (en) 1992-09-17
ATE110277T1 (de) 1994-09-15
US5068221A (en) 1991-11-26
DE69011857T2 (de) 1995-03-23
WO1990013308A1 (en) 1990-11-15
AU5559590A (en) 1990-11-29
DE69011857D1 (de) 1994-09-29
AU1620392A (en) 1992-07-30
NZ248242A (en) 1997-07-27
CA2053880A1 (en) 1990-11-10
JPH04505016A (ja) 1992-09-03
IL94330A0 (en) 1991-03-10
AU639403B2 (en) 1993-07-22
EP0471761B1 (en) 1994-08-24
KR920700676A (ko) 1992-08-10
CA2053880C (en) 1997-01-14

Similar Documents

Publication Publication Date Title
ES2144398T3 (es) Tratamiento mejorado de enfermedades autoinmunes mediante la administracion en aerosol de autoantigenos.
OA08581A (en) Treatment of diseases caused by retroviruses.
NO895066L (no) Implantat til erstatning av en tann eller en del av benvevet.
NO884124L (no) Kapasitivt maaleapparat for tomroms-andel.
ES2019570B3 (es) Dispositivo para el tratamiento termico del cuello de los preformados.
EP0292554A4 (en) MOISTURE RESISTANT SKIN TREATMENT COMPOSITIONS.
IT9067204A0 (it) Dispositivo per assistenza ventricolare cardiaca, particolarmente per il ricupero della funzione miocardica depressa e per il mantenimento delle funzioni vitali dell'organismo
ES2057565T3 (es) Tratamiento de trastornos de la motilidad con un analogo de gnrh.
DE3880849D1 (de) Endoskop mit koerperhoehlendruckeinstellgeraet.
DE3863159D1 (de) Blutdruckmanschettenhalterung.
BR9712466A (pt) Aplicação de adamantanaminas ou compostos de estrutura análogo para combater o vìrus da doença de borna e para a profilaxia e tratamento de doenças emocionais e outras perturbaçoes ligadas com infecçoes do vìrus bd homem e animal
FR2651435B1 (es)
FI873428A7 (fi) Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon.
EP0437929A3 (en) Use of diadenosine-5',5'''-p1,p4-tetraphosphate for the manufacture of a medicament for the treatment of heart disease
ITMI911578A1 (it) Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione.
IT1225483B (it) Protesi ortopedica, particolarmente per la testa del femore.
NO880292L (no) Fremgangsmaate for behandling av humle.
IT1245629B (it) Dispositivo per estrarre spirali elettrodiche incarnate in un organo del corpo umano.
NO881303D0 (no) Underlag for pasientseng.
PT92866A (pt) Metodo para o tratamento de sindroma pre-menstrual, utilizando melatonina
KR880002525A (ko) 뇌 허혈성 병을 수반하는 질환 치료제
IT208524Z2 (it) Telo attrezzato, atto ad isolare un arto, destinato ad interventi chirurgici, di un paziente, dal tronco del paziente stesso.
RO94261A2 (ro) Produs medicamentos destinat tulburarilor de dinamica sexuala
IT8722095A0 (it) Struttura di mutande a calzoncino particolarmente studiate per rivestire la porzione inferiore del tronco di persone defunte.
IT8709499A0 (it) Sistema meccanico montato su macchine da calzini o da calza, mono o doppio cilindro con il quale si ottiene la punta chiusa, rammagliata del calzino o della calza

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 471761

Country of ref document: ES